Can a Calcium Deposit in the Shoulder Go Away on Its Own?
Updated: Sep 8
Short answer: calcific tendinopathy of the rotator cuff can often be treated non-invasively with high-energy focused shockwave therapy. In a randomised controlled trial published in JAMA (Gerdesmeyer et al., 2003), high-energy focused shockwave produced significantly greater improvement in shoulder function and higher rates of complete deposit resorption than both low-energy treatment and sham. International guidance specifically recommends focused generators at high energy for calcifications which is why availability, not evidence, is the usual barrier in New Zealand.
If you’ve had an ultrasound or X-ray showing calcium in your rotator cuff, you’ve probably been told your options are to wait it out, have a cortisone injection, have the deposit needled (barbotage), or have surgery. This article covers the option that’s often missing from that list, what the evidence actually shows, and just as importantly who it isn’t right for.
What calcific tendinopathy actually is
Calcific tendinopathy occurs when calcium hydroxyapatite crystals deposit within a tendon, most commonly the supraspinatus of the rotator cuff. It affects roughly 3–10% of adults, typically between 30 and 60, and is more common in women. There’s an association with diabetes and thyroid disorders.
Critically, it is not a wear-and-tear phenomenon, not caused by dietary calcium, and not the same as rotator cuff tear or shoulder osteoarthritis although it can coexist with them. Many people carry deposits without symptoms at all.
The condition is generally described in phases:
Pre-calcific - tissue changes precede visible deposit
Formative - calcium accumulates; often relatively silent or mildly symptomatic. The deposit at this stage is dense and chalk-like
Resting - stable deposit; symptoms variable
Resorptive - the body mounts an active response to break the deposit down; it becomes soft, toothpaste-like, and intratendinous pressure rises sharply
The resorptive phase is why calcific tendinopathy has a reputation for extreme pain. Patients describe pain that is disproportionate to any injury, severe night pain, inability to lie on the shoulder, and in acute crises, pain comparable to a fracture. It is one of the few musculoskeletal conditions that regularly sends people to emergency departments.
Not all deposits are equal: the Gärtner classification
When we review your imaging, one of the first things we're looking at is what kind of deposit you have, because it changes both the treatment plan and the honest prognosis. The most widely used radiographic system is the Gärtner classification:
Gärtner I - sharply bordered, homogeneous, dense. The classic chalk-like formative-phase deposit
Gärtner II - sharply bordered but inhomogeneous in structure, an intermediate picture
Gärtner III - inhomogeneous in both border and structure. Translucent, fragmenting, a deposit the body is already actively breaking down
This maps loosely onto the phases described above: type I deposits tend to sit in the formative or resting phase, while type III appearances usually mean resorption is underway. The clinical implications cut both ways. Type III deposits often resolve relatively quickly on their own but with notoriously variable symptoms along the way, and they're the deposits driving the acute crises described earlier. Type I and II deposits are slower-moving and more predictable, and they are precisely the deposits for which high-energy focused shockwave is indicated: dense, well-circumscribed calcium that the body isn't yet clearing, in a shoulder that's been symptomatic for more than six months despite conservative care. Ultrasound adds useful real-time information about deposit consistency and tendon involvement alongside the X-ray picture, which is why we review both where available.
This is also why "shockwave for calcific shoulder" can't be applied generically. The classification tells us whether your deposit is the kind the evidence applies to and if it isn't, we'll tell you that at assessment, not after eight sessions.
The natural history argument and its limits
Calcific tendinopathy is frequently self-limiting. Deposits do resorb spontaneously in many people, which is the basis for “wait and see” advice.
Two things complicate that. First, “eventually” can mean months to years. Second, a shoulder held still for months develops secondary problems: capsular stiffness, rotator cuff deconditioning, altered scapular mechanics, and in some cases a genuine secondary frozen shoulder. This is the clearest possible illustration of our clinic’s founding idea Movement Matters™: the absence of movement leads to the presence of pathology. The deposit may resolve on its own; the shoulder that spent a year guarding against it often doesn’t.
So the question isn’t only “will it go away?” It’s “what condition will my shoulder be in when it does?”
The standard treatment ladder and where the gap is
Watchful waiting and analgesia. Reasonable for mild, non-progressive symptoms. Difficult to justify through a severe resorptive phase.
Physiotherapy and exercise. Valuable for maintaining range, scapular control and cuff capacity and essential alongside any other treatment. But exercise cannot break down a calcium deposit, and heavy loading through an acutely inflamed calcific tendon is often poorly tolerated.
Corticosteroid injection. Can settle a severe flare and has a place in acute crisis management. It does not affect the deposit, benefits commonly fade, and repeated injections carry cumulative tendon risk. It also delays shockwave by 6–12 weeks, which matters if you’re considering both see shockwave therapy vs cortisone injections.
Ultrasound-guided needling / barbotage (lavage). A radiologist needles the deposit under ultrasound and aspirates or lavages it. Effective for many patients, particularly with soft resorptive-phase deposits. It is invasive, operator-dependent, uncomfortable, and less effective against hard formative-phase deposits. Comparative randomised research has examined needling against shockwave with both showing benefit and differing profiles.
Arthroscopic surgical removal. Reserved for failure of conservative management. Effective, but it is surgery: anaesthetic, recovery period, rehabilitation, and cost.
The gap in this ladder, in most New Zealand practices, sits between steps 3 and 4 a non-invasive treatment with randomised evidence that acts on the deposit itself.
What the evidence shows for focused shockwave
The landmark trial is Gerdesmeyer L, Wagenpfeil S, Haake M, et al. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA. 2003;290(19):2573–2580.
Design and findings:
144 patients with chronic calcifying tendonitis (symptoms ≥6 months, failed conservative treatment)
Randomised to high-energy focused ESWT, low-energy focused ESWT, or sham
Both active treatment groups significantly outperformed sham on the Constant-Murley shoulder score at six months
High-energy outperformed low-energy on both symptom and radiographic outcomes
Complete or partial deposit resorption occurred substantially more often in the high-energy group than sham
Subsequent systematic reviews of shockwave for shoulder calcific tendonitis have broadly supported these findings, with the consistent message that energy level and device type matter: higher-energy focused treatment produces better structural outcomes than low-energy or radial approaches for this specific indication.
This is why the ISMST recommends focused generators at high energy levels for calcifications, and why we discuss the distinction at length in our guide to choosing between focused and radial shockwave. A calcium deposit sitting several centimetres deep in the supraspinatus is precisely the target a radial pressure wave is least suited to reach at therapeutic dose.
The numbers, for those who want them
Headline conclusions are easy to assert, so here is what the JAMA trial actually measured. Shoulder function was assessed on the Constant-Murley Score the standard 100-point instrument combining pain, activities of daily living, range of motion and strength. At six months, mean improvement was 31.0 points in the high-energy group, 15.0 points in the low-energy group, and 6.6 points with sham. That's roughly a five-fold difference between high-energy treatment and placebo, with the gap between groups widening from three months onward a clear dose-response relationship, sustained through twelve months.
The structural findings were just as striking. Complete disappearance of the calcific deposit occurred in 60% of the high-energy group, 21% of the low-energy group, and 11% of the sham group. Sit with that comparison for a moment: the placebo figure is essentially the natural resorption rate over the study period, and high-energy focused shockwave nearly sextupled it.
Two details are worth noting honestly. The treatment course was just two fluoroscopy-guided sessions about two weeks apart, with both active groups receiving the same cumulative energy so the difference came from energy per pulse, not total dose. And all groups received standardised physiotherapy afterwards, which is one more piece of evidence that shockwave belongs inside a rehabilitation plan, not instead of one. That dose-dependence is also exactly why treatment parameters matter: energy flux density, pulse count and patient selection are what separate the published outcomes from generic "shockwave" applied at whatever setting the machine happens to be on.
How the mechanism works
Focused shockwave acts on calcific tendinopathy through two parallel pathways:
On the deposit - converged high-energy acoustic pulses generate mechanical stress and cavitation effects at the deposit, fragmenting it and accelerating the body’s own resorptive process. The fragmented material is then cleared by normal phagocytic activity.
On the tendon - the same treatment stimulates mechanotransduction, neovascularisation and collagen remodelling in the surrounding tendon, while modulating neurogenic inflammation (substance P, CGRP) that drives pain sensitisation.
That dual action is the appeal: it targets the structural problem and the pain mechanism, without a needle, a drug or an incision.
Have imaging showing a calcium deposit?
Bring the report. Book an assessment with Jonathan Hall (M.Ost) EMS DolorClast® Key Opinion Leader for Aotearoa and find out whether focused shockwave is appropriate for your deposit. Book an appointment → · Browns Bay · GP and specialist referrals welcome.
How we treat calcific shoulders at Movement Mechanics
Focused shockwave leads, but it is never the whole plan.
Assessment and imaging review
We review existing ultrasound or X-ray, confirm the diagnosis clinically, identify the likely phase (formative vs resorptive), and screen for coexisting rotator cuff pathology, subacromial bursopathy or capsular restriction. Where imaging is absent or outdated, we refer we’re located inside Bays Health alongside GP and imaging pathways.
EMS DolorClast® focused shockwave targeted to the deposit, typically 4–8 sessions at weekly intervals, energy titrated to tolerance and to the deposit’s characteristics. We are currently the only clinic in Aotearoa operating this device (as at 2026).
High-power laser during irritable phases
Where the shoulder is acutely inflamed particularly in the resorptive phase EMS DolorClast® high-power laser therapy (905 nm) is used to modulate neurogenic inflammation and pain sensitivity, making both treatment and movement more tolerable. The rationale for combining the two modalities is covered in our article on the therapeutic synergy of laser and shockwave.
Osteopathic treatment and rehabilitation
A painful shoulder never fails in isolation. We treat the thoracic spine, scapular mechanics, cervical contributors and the compensations that months of guarding produce, then rebuild rotator cuff capacity progressively. Related: supraspinatus tendinopathy and rotator cuff tears and our osteopathy approach.
Defined review points
We set explicit milestones. If symptoms and function aren’t tracking, we say so and we help you escalate to barbotage or an orthopaedic opinion with your imaging and our clinical notes in hand. The promise is avoiding unnecessaryprocedures, not avoiding all of them.
How we know it's working
"Feeling better" matters most, but it isn't the only measure and on its own it can mislead in both directions. We track progress on three fronts. Functionally, using standardised assessment of pain, daily activities, range and strength the same Constant-Murley domains used in the trial evidence, so your progress can be benchmarked against published outcomes rather than guesswork.
Symptomatically, through pain scores and, tellingly, sleep. And structurally, through follow-up imaging where indicated, since deposit resorption after shockwave happens gradually over weeks to months.
One honest caveat: imaging changes typically lag behind symptomatic improvement. A shoulder can feel dramatically better while the X-ray still shows calcium, and occasionally the reverse. That's why we correlate all three rather than treating any single measure as the verdict and why the 12-week post-course review exists. If the multidimensional picture isn't tracking, that's the trigger for escalation, with your imaging and our serial outcome data in hand.
Who responds best
The flip side of contraindications is the profile of the patient most likely to do well and it's more specific than "has a calcific shoulder." The evidence-based candidate looks like this: chronic shoulder pain persisting beyond three to six months, a structured course of rehabilitation already tried without resolution, and an imaging-confirmed Gärtner I or II deposit. That triad confirmed calcification, six-plus months of symptoms, frustrated conservative treatment is essentially the indication set the international literature and ISMST guidance describe, and it's the population the JAMA trial recruited.
Beyond that, functional demand matters. Patients with high physical requirements manual work, overhead trades, sport often benefit from a structured, protocolised course precisely because their shoulder can't afford a year of guarded waiting. Comorbidities, medication use and previous interventions all feed into the plan rather than ruling it out; they're why assessment comes first.
Careful selection isn't gatekeeping it's what makes the published success rates reproducible in clinic, and it's how unnecessary procedures get avoided on both sides: no shockwave for the deposit that's already resorbing on its own, and no surgery for the deposit that two sessions of properly dosed focused treatment could have cleared.
Who focused shockwave is not right for
Honesty is the point of this section. Shockwave is not appropriate if:
You are pregnant
You have a blood clotting disorder or are taking anticoagulants (requires GP coordination and case-by-case assessment)
There is local malignancy or active bacterial or viral infection at the treatment site
You’ve had a corticosteroid injection within the preceding six weeks
You are under 18 (with limited exceptions such as Osgood-Schlatter disease)
It is also not the answer if the shoulder pain is being driven by something else a large rotator cuff tear, significant glenohumeral arthritis, cervical referral, or an inflammatory arthropathy. Assessment exists to establish that before treatment starts. Our full FAQs cover contraindications in more detail, as does our article on shockwave, blood thinners and steroids.
Frequently asked questions
Can calcium deposits in the shoulder go away without surgery?
Yes. Many deposits resorb spontaneously over months to years, and treatment can accelerate that process. In a randomised controlled trial published in JAMA, high-energy focused shockwave therapy produced significantly greater symptom improvement and higher rates of deposit resorption than sham treatment in chronic cases.
How successful is shockwave therapy for calcific tendinopathy?
Randomised and systematic review evidence shows meaningful improvements in pain and shoulder function, with partial or complete deposit resorption in a substantial proportion of patients treated with high-energy focused shockwave. Individual outcomes depend on deposit size, density and phase, which is why imaging review comes first.
Is shockwave therapy for a calcific shoulder painful?
Treating a calcific deposit is one of the more uncomfortable shockwave applications, because effective treatment requires higher energy. Intensity is titrated to your tolerance, sessions last only a few minutes per site, and there’s no downtime. Most patients find it very manageable relative to the night pain they’re already experiencing.
How many sessions will I need?
Typically 4–8 sessions at weekly intervals. As with other shockwave indications, outcomes continue improving for around 12 weeks after the course, so final assessment happens at that point.
Shockwave or barbotage which is better?
Both have supporting evidence. Barbotage is invasive but can remove deposit material directly and works well with soft resorptive-phase deposits. Focused shockwave is non-invasive, treats the surrounding tendon as well as the deposit, and suits harder formative-phase deposits that needles struggle with. The right choice depends on your deposit and your preferences we’ll give you an honest view, including when we think barbotage is the better option.
Will the calcium come back after treatment?
Recurrence after successful resorption is uncommon. The more common long-term issue is a shoulder left weak and stiff by a long period of guarding, which is why rehabilitation is built into the plan.
Do I need a referral or new imaging?
No referral is required. Existing ultrasound or X-ray reports are extremely helpful bring them. Where imaging is needed or out of date, we can refer you.
Is treatment covered by ACC or Southern Cross?
Where an injury-related claim applies, we can lodge an ACC claim note that calcific tendinopathy is often not injury-related, in which case standard fees apply. We are Southern Cross Easy-claim providers. Current pricing is on our fees page.
I’m booked for surgery. Is it too late to try this?
Not necessarily, and it’s worth a conversation including about optimising the shoulder before surgery if you proceed. We work with patients before and after operations through our surgical recovery programme.
The bottom line
A calcium deposit in the rotator cuff produces genuinely severe pain, and the standard New Zealand pathway tends to move from waiting to needles to surgery. There is a well-evidenced, non-invasive step in between that most patients are never offered not because the evidence is weak, but because the device required to deliver it properly is rare in this country.
That’s precisely why we invested in it. Being able to offer patients a guideline-recommended, non-invasive alternative to injections and surgery is the entire point of the technology we’ve built the clinic around.
Sleep on that shoulder again
Book with Jonathan Hall → Aotearoa’s only EMS DolorClast® focused shockwave clinic. Browns Bay, Monday to Saturday. Or call 09 884 0935.
References
Gerdesmeyer L, Wagenpfeil S, Haake M, et al. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA. 2003;290(19):2573–2580.
International Society for Medical Shockwave Treatment (ISMST). Indications for shockwave therapy.
Bannuru RR, Flavin NE, Vaysbrot E, Harvey W, McAlindon T. High-energy extracorporeal shock-wave therapy for treating chronic calcific tendinitis of the shoulder: a systematic review. Ann Intern Med. 2014;160(8):542–549.
Kim YS, Lee HJ, Kim YV, Kong CG. Which method is more effective in treatment of calcific tendinitis in the shoulder? Prospective randomized comparison between ultrasound-guided needling and extracorporeal shock wave therapy. J Shoulder Elbow Surg. 2014;23(11):1640–1646.
Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751–1767.
This article is general information, not individual clinical advice. Treatment recommendations require assessment.
Comments